34 y/o Female With JAK2 V617F Mutated Polycythemia Vera: What PV Treatment Should Be Considered? How Can We Identify the Risks?
SOHO 2020 on-demand content is available through January 12, 2021. To access the virtual environment, ...
read more ↘
read more ↘
Login to view comments.
Click here to Login
